by Hemangio | Nov 18, 2024 | Treatments
When your dog is diagnosed with hemangiosarcoma and you start looking into treatment options, you’ll likely come across clinical trials. As an owner, the idea of your dog being tested with something still in the trial phase can feel overwhelming, especially when time...
by Hemangio | May 31, 2024 | Hemangio Journal
Published: May. 21, 2024. Heather Gardner, D.V.M., Ph.D., a veterinary oncologist and assistant professor at Cummings School of Veterinary Medicine at Tufts University, has dedicated investigations to many cancers such as osteosarcoma and lymphoma. In cases of...
by Hemangio | Apr 26, 2024 | Hemangio Journal
Published: April 26, 2024. Hemangiosarcoma (HSA) and hemangioma (HMA) are both tumors that develop in canines from blood vessel cells. As similar as these two are in specifics, hemangiosarcoma develops as an aggressive cancer that tends to spread...
by Hemangio | Apr 30, 2024 | Hemangio Journal
Published: April, 12, 2024. In a section of the Small Animal Clinical Oncology textbook re-edited in 2020, a chart shows a compilation of studies and treatments used in dogs after splenectomy. Median survival times with only splenectomy were between 19...
by Hemangio | Apr 12, 2024 | Hemangio Journal
Published: April 10, 2024. Antech, a company specializing in veterinary diagnostics for wellness and disease, has released two innovative diagnostic tools to support clinical decision-making to better the outcome of patients. The first is AIS RapidRead®, which...
